| |
|
|
|
INmune Bio Inc.  
|
|
5.03 -0.03 (-0.01%) |
07-02 16:00 |
|
Open: |
5.04 |
Pre close: |
5.06 |
Target:
|
6.60 
|
|
High: |
5.05 |
Low: |
4.5 |
Resistance:
|
5.65
6.36
|
|
Volume: |
69,363 |
Market Cap: |
54M |
Support:
|
4.50
3.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.34
|
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
5.53 |
Signal(12,26,9): |
0.07 |
|
MA(100): |
4.63 |
Stochastic Oscillator |
%K(14,3):
|
18.66  |
|
MA(250): |
5.36 |
%D(3): |
23.40 |
|
Average Volume(K) |
3-Month: |
4798
|
52-Week |
High:
|
10.35 |
|
10-Days: |
6956 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
42.06 |
Change(%): |
-49.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.740 |
Return on Equity (ttm) |
-34.7 |
Shares Out. (M) |
10.82 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-25.0 |
Shares Float (M) |
3.86 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
58.23 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.60 |
|
Forward EPS |
-0.750 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
7 |
|
Book Value (p.s.) |
2.090 |
EBITDA (p.s.) |
0.000 |
P/E |
-6.80 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.41 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.03 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.31 |
P/CF |
-10.82 |
|
|
|
|
|
|
